Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Understanding CAN/CSA-C22.2 No. 60601-2-43-11 AMD1:2019 – Safety Requirements for Interventional X-Ray Equipment
Comprehensive Guide to the Canadian Adoption of IEC 60601-2-43 with Amendment 1 for Medical Electrical Equipment
CAN/CSA-C22.2 No. 60601-2-43-11 AMD1:2019 represents the Canadian national adoption of IEC 60601-2-43:2010 together with Amendment 1:2017. This standard establishes particular safety and essential performance requirements for X-ray equipment intended for interventional procedures, including fluoroscopy, angiography, and hybrid systems. As part of the C22.2 series under the Canadian Electrical Code, Part 2, this standard is mandatory for all medical electrical equipment marketed in Canada. This article explains the scope, technical requirements, implementation aspects, and compliance obligations for manufacturers and testing bodies.
1. Scope and Application
The standard applies to medical electrical equipment and systems that produce X-ray images during interventional procedures where real-time image guidance is used for minimally invasive interventions. This includes fixed, mobile, and ceiling-mounted C-arms, as well as dedicated interventional X-ray systems.
Tip: Equipment that is also intended for general-purpose fluoroscopy but not specifically for interventional use may fall outside the scope. Manufacturers should verify the intended clinical use in the risk management file.
The standard explicitly excludes equipment designed primarily for:
- Mammography (covered by IEC 60601-2-45)
- Computed tomography (IEC 60601-2-44)
- Radiotherapy (IEC 60601-2-1, etc.)
- Dental X-ray (IEC 60601-2-63)
Amendment 1 (AMD1:2019) improves definitions and clarifies requirements for protective devices, user interface accuracy, and the handling of cumulative radiation dose information.
2. Technical Requirements and Essential Performance
The standard defines several mandatory technical performance metrics, many of which are directly linked to patient and staff radiation safety. These requirements are summarized in the table below:
| Clause | Requirement | Specification / Tolerance |
|---|---|---|
| 201.12.1.101 | Reference air kerma rate accuracy | ±10 % over the range 60 kV to 120 kV |
| 201.12.4.2 | Cumulative air kerma (CAK) display | Indication within ±25 % of the true value |
| 201.12.4.3 | Dose area product (DAP) indication | ±35 % deviation allowed |
| 201.13 | Protective devices & collimation | Automatic collimation of X‑ray beam; ceiling‑suspended shields must attenuate ≥0.25 mm Pb equivalent |
| 201.14 | Essential performance of AEC | Automatic exposure control must maintain optical density within ±15 % of reference |
Radiation Protection and Dose Management
A significant portion of the standard focuses on radiation dose monitoring and control. Equipment must provide real-time display of cumulative air kerma and DAP. If a dose threshold (e.g., 1000 mGy) is exceeded, an audible or visual alarm must activate. The 2019 amendment clarifies that these dose values should be non‑resettable while the patient is on the table, ensuring accurate recording.
Caution: The amendment also introduces more stringent requirements for the user interface. Manufacturers must ensure that dose information is not obscured by other graphical elements and remains visible from the operator’s normal working position.
Image Quality and Fluoroscopic Performance
Essential performance includes the ability to image objects of low contrast and small size. The standard mandates specific measured performance for spatial resolution (typically 0.6 lp/mm or better for 23 cm FOV) and low‑contrast detectability. These metrics are verified using specified phantoms.
Compliance note: Meeting the image quality requirements is often the most challenging part of the certification process. Pre‑testing with the phantom defined in the normative annexes can prevent costly redesigns.
3. Implementation Highlights for Manufacturers
Integrating the requirements of CAN/CSA-C22.2 No. 60601-2-43-11 AMD1:2019 into a quality management system requires careful planning. Key areas include:
- Risk management per ISO 14971:2019 – The hazard analysis must address specific interventional risks such as unintentional high dose, skin injury, and equipment collisions during complex positioning.
- Software verification – Display of dose values, alarm thresholds, and recording functions must be validated. The amendment stresses the need for cybersecurity controls to prevent modification of dose data.
- Usability engineering – IEC 62366-1 applies. The user interface for dose management must be examined through formative and summative evaluations.
- Labeling and documentation – Instructions must include warnings about radiation risks for interventional use, and specify training requirements for operators.
Tip: When updating an existing X‑ray system design to meet the 2019 amendment, pay close attention to non‑resettability of cumulative dose indicators. Many field‑installed systems require hardware modification.
4. Compliance and Certification Notes
In Canada, compliance with CAN/CSA-C22.2 No. 60601-2-43-11 AMD1:2019 is required to obtain a CSA certification mark or another recognized certification mark from an accredited body (e.g., SCC‑accredited laboratory). The certification process generally includes:
- Type testing of a representative sample to all relevant clauses.
- Review of the risk management file and software documentation.
- Factory inspection for quality system conformity.
- Annual follow‑up inspections and product testing.
Because the standard is a full adoption of IEC 60601-2-43:2010 + AMD1:2017, certification obtained under the IEC version is not automatically recognized as equivalent in Canada. Manufacturers must apply for a Canadian national deviation assessment when differences exist.
Important: As of 2026, Health Canada may require evidence of compliance with the latest CSA standard during Medical Device Establishment License (MDEL) renewals or new device license applications. Ensure your technical files are up to date.
Frequently Asked Questions
Q: Does CAN/CSA-C22.2 No. 60601-2-43-11 AMD1:2019 apply to existing interventional X‑ray systems that are already marketed?
A: Generally, the standard applies to new equipment placed on the market after the publication date. However, any significant modification to a legacy system (e.g., software update that changes dose display) may trigger the need to comply with the amended requirements.
A: Generally, the standard applies to new equipment placed on the market after the publication date. However, any significant modification to a legacy system (e.g., software update that changes dose display) may trigger the need to comply with the amended requirements.
Q: What is the main change introduced by Amendment 1 (2019)?
A: The amendment clarifies the non‑resettable nature of cumulative dose indicators, updates the accuracy tolerances for DAP under pulsed fluoroscopy, and harmonizes the requirements for protective devices (e.g., patient drapes and ceiling‑suspended shields).
A: The amendment clarifies the non‑resettable nature of cumulative dose indicators, updates the accuracy tolerances for DAP under pulsed fluoroscopy, and harmonizes the requirements for protective devices (e.g., patient drapes and ceiling‑suspended shields).
Q: Can I use an IEC 60601-2-43 test report for Canadian certification?
A: Yes, but only if the testing laboratory is accredited by a recognized Canadian accreditation body and the report covers all Canadian national deviations. Often a supplementary gap analysis is required for the specific clauses modified by CSA.
A: Yes, but only if the testing laboratory is accredited by a recognized Canadian accreditation body and the report covers all Canadian national deviations. Often a supplementary gap analysis is required for the specific clauses modified by CSA.
Q: Are there additional requirements beyond the IEC base standard?
A: The C22.2 series imposes some additional electrical safety and environmental conditions. However, for this particular standard, the adoption is essentially identical to the IEC version, provided the equipment is intended for installation in accordance with the Canadian Electrical Code (CE Code Part I).
A: The C22.2 series imposes some additional electrical safety and environmental conditions. However, for this particular standard, the adoption is essentially identical to the IEC version, provided the equipment is intended for installation in accordance with the Canadian Electrical Code (CE Code Part I).
© 2026 Canadian Standards Association. All rights reserved. This article is for informational purposes only and does not replace the full standard text. Users should refer to the official published standard and consult with qualified regulatory professionals.